SCHEMBL14697124

SCHEMBL14697124

O=c1c2c(F)cccc2nc(S)n1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 11/20 0.44
▸ PIK3CD O00329 11/20 0.44
▸ PIK3CB P42338 10/20 0.44
▸ PIK3CA P42336 8/20 0.44
▸ PIK3R1 P27986 8/20 0.44
▸ PDE4D Q08499 2/20 0.42
▸ PIK3R2 O00459 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ PRKDC P78527 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ PIK3C3 Q8NEB9 1/20 0.42
▸ TRPV4 Q9HBA0 1/20 0.42
▸ HRH3 Q9Y5N1 2/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9670318 0.82 PIK3CD (0.49) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL16596952 0.82 HRH3 (0.57) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL14697463 0.81 PDE4B (0.43) PIK3CGPIK3CDPDE4DPIK3R2TRPV4
SCHEMBL16021382 0.81 TRPV4 (0.39) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL14697173 0.81 SMN1; SMN2 (0.40) PIK3CGPIK3CDPDE4DTRPV4HRH3
SCHEMBL14697302 0.81 TRPV4 (0.39) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL18896600 0.79 NPC1 (0.47) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL16597182 0.79 SMN1; SMN2 (0.50) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL20061285 0.79 PIK3CG (0.57) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1
SCHEMBL16591389 0.79 TRPV4 (0.45) PIK3CGPIK3CDPIK3CBPIK3CAPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10611733-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2020-04-07 — — US disclosed
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE 2017-05-25 — — US disclosed
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE 2017-05-25 — — US disclosed
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE 2017-05-25 — — US disclosed
US-9598402-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SOUTHERN RESEARCH INSTITUTE (US) 2017-03-21 — — US disclosed
US-9598402-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SOUTHERN RESEARCH INSTITUTE (US) 2017-03-21 — — US disclosed
US-9598402-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections SOUTHERN RESEARCH INSTITUTE (US) 2017-03-21 — — US disclosed
EP-2744787-B1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RES INST (US) 2016-11-02 — — EP disclosed
EP-2744787-B1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RES INST (US) 2016-11-02 — — EP disclosed
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-09-11 — — US disclosed
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-09-11 — — US disclosed
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-09-11 — — US disclosed
EP-2744787-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS Southern Research Institute (US) 2014-06-25 — — EP disclosed
WO-2013025508-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS SOUTHERN RESEARCH INSTITUTE (US) 2013-02-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256753-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS HAVCR2, EIF2AK2, GLS2 PIK3CG 4023/4885PIK3CD 4124/4885PIK3CB 3099/4885
US-20170144978-A1 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONS ZC3HAV1, EIF2AK2, GTF3C3 PIK3CG 3977/4885PIK3CD 4204/4885PIK3CB 2986/4885
US-10611733-B2 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections ZC3HAV1, EIF2AK2, GTF3C3 PIK3CG 3977/4885PIK3CD 4204/4885PIK3CB 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback